Immunovia completes analytical validation of its next-generation pancreatic cancer test

Contributed by: PR Newswire

Tags

IMMUNOVIA-Test

More Like This

Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer

Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test

Immunovia successfully completes discovery phase of next-generation test development

Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study

Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy

Immunovia files US patent application to protect its next-generation test

Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference

Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health